Comorbidities at multiple sclerosis diagnosis

Journal of Neurology

Volumn 260, Issue 10, 2013, Pages 2629-2637

  Fromont, Agnès ^a,b,d   Binquet, Christine ^a,c,d   Rollot, Fabien ^a,c,d   Despalins, Romain ^a,c,d   Weill, Alain ^e   Clerc, Laurence ^f   Bonithon Kopp, Claire ^a,c,d   Moreau, Thibault ^a,b,d  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b EA 4184   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE BOURGOGNE   (France)

^e French Public Health Insurance   (France)

^f Public Health Insurance Regional Direction of the Medical Department   (France)

Author keywords

Comorbidity; Epidemiology; Multiple sclerosis

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; COMORBIDITY; DIABETES MELLITUS; FEMALE; FRANCE; HUMAN; LUPUS VULGARIS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; METABOLIC DISORDER; MULTIPLE SCLEROSIS; NEOPLASM; POLYARTERITIS NODOSA; PRIORITY JOURNAL; SPONDYLITIS; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; CHRONIC DISEASE; COMORBIDITY; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RETROSPECTIVE STUDIES; SEX FACTORS; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84886098870     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-013-7041-9     Document Type: Article

References (33)

1. Achiron A, Barak Y, Gail M, Mandel M, Pee D, Ayyagari R, Rotstein Z (2005) Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments. Breast Cancer Res Treat 89:265-270
2. Alcina A, Fedetz M, Ndagire D, Fernandez O, Leyva L, Guerrero M, Abad-Grau MM, Arnal C, Delgado C, Lucas M, Izquierdo G, Matesanz F (2009) IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D). PLoS One 4:e4137
3. Bahmanyar S, Montgomery SM, Hillert J, Ekbom A, Olsson T (2009) Cancer risk among patients with multiple sclerosis and their parents. Neurology 72:1170-1177
4. Baranzini SE (2009) The genetics of autoimmune diseases: a networked perspective. Curr Opin Immunol 21:596-605
5. Buchanam R, Schiffer R, Stuifbergen A et al (2006) Demographic and disease characteristics of people with multiple sclerosis living in urban and rural areas. Int J MS Care 8:89-98
6. Cotsapas C, Voight BF, Rossin E, Lage K, Neale BM, Wallace C, Abecasis GR, Barrett JC, Behrens T, Cho J, De Jager PL, Elder JT, Graham RR, Gregersen P, Klareskog L, Siminovitch KA, van Heel DA, Wijmenga C, Worthington J, Todd JA, Hafler DA, Rich SS, Daly MJ (2011) Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet 7:e1002254
7. Dorman JS, Steenkiste AR, Burke JP, Songini M (2003) Type 1 diabetes and multiple sclerosis: together at last. Diabetes Care 26:3192-3193
8. Feinstein A (1970) The pre-therapeutic classification of comorbidity in chronic disease. J Chron Dis 23:455-468
9. Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, van den Bos GA (2001) Causes and consequences of comorbidity: a review. J Clin Epidemiol 54:661-674
10. Gout O (2011) Prior suggestive symptoms in one third of patients consulting for a first demyelinating event. J Neurol Neurosurg Psychiatry 82:323-325
11. Guralnik JM (1996) Assessing the impact of comorbidity in the older population. Ann Epidemiol 6:376-380
12. Handel AE, Ramagopalan SV (2010) Multiple sclerosis and risk of cancer: a meta-analysis. J Neurol Neurosurg Psychiatry 81:1413-1414
13. Hoffman C, Rice D, Sung HY (1996) Persons with chronic conditions. Their prevalence and costs. JAMA 276:1473-1479
14. Langer-Gould A, Albers KB, Van Den Eeden SK, Nelson LM (2010) Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study. Mult Scler 16:855-861
15. Lo Fermo S, Barone R, Patti F, Laisa P, Cavallaro TL, Nicoletti A, Zappia M (2010) Outcome of psychiatric symptoms presenting at onset of multiple sclerosis: a retrospective study. Mult Scler 16:742-748
16. Maier LM, Lowe CE, Cooper J, Downes K, Anderson DE, Severson C, Clark PM, Healy B, Walker N, Aubin C, Oksenberg JR, Hauser SL, Compston A, Sawcer S, De Jager PL, Wicker LS, Todd JA, Hafler DA (2009) IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genet 5:e1000322
17. Marrie R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T (2008) Comorbidity, socioeconomic status and multiple sclerosis. Mult Scler 14:1091-1098
18. Marrie RA, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T (2009) The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated. Mult Scler 15:385-392
19. Marrie RA, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T (2009) Comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology 72:117-124
20. Marrie RA, Yu BN, Leung S, Elliott L, Caetano P, Warren S, Wolfson C, Patten SB, Svenson LW, Tremlett H, Fisk J, Blanchard JF (2012) Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia. Mult Scler 18:1310-1319
21. Marrosu MG, Cocco E, Lai M, Spinicci G, Pischedda MP, Contu P (2002) Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: a cohort study. Lancet 359:1461-1465
22. Moller H, Kneller RW, Boice JD Jr, Olsen JH (1991) Cancer incidence following hospitalization for multiple sclerosis in Denmark. Acta Neurol Scand 84:214-220
23. Nielsen NM, Westergaard T, Frisch M, Rostgaard K, Wohlfahrt J, Koch-Henriksen N, Melbye M, Hjalgrim H (2006) Type 1 diabetes and multiple sclerosis: a Danish population-based cohort study. Arch Neurol 63:1001-1004
24. Owens G (2008) Gender differences in health care expenditures, resource utilization, and quality of care. J Manag Care Pharm 14:2-6
25. Percy AK, Nobrega FT, Okazaki H, Glattre E, Kurland LT (1971) Multiple sclerosis in Rochester, Minn. A 60-year appraisal. Arch Neurol 25:105-111
26. Ramagopalan SV, Dyment DA, Valdar W, Herrera BM, Criscuoli M, Yee IM, Sadovnick AD, Ebers GC (2007) Autoimmune disease in families with multiple sclerosis: a population-based study. Lancet Neurol 6:604-610
27. Reffet S, Thivolet C (2007) Type 1 diabetes of the child and adult. Rev Prat 57:71-78
28. Rochon PA, Katz JN, Morrow LA, McGlinchey-Berroth R, Ahlquist MM, Sarkarati M, Minaker KL (1996) Comorbid illness is associated with survival and length of hospital stay in patients with chronic disability. A prospective comparison of three comorbidity indices. Med Care 34:1093-1101
29. Roshanisefat H, Bahmanyar S, Hillert J, Olsson T, Montgomery S (2012) Shared genetic factors may not explain the raised risk of comorbid inflammatory diseases in multiple sclerosis. Mult Scler 18:1430-1436
30. Shapira Y, Agmon-Levin N, Shoenfeld Y (2009) Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 34:J168-J177
31. Van den Akker M, Buntinx F, Metsemakers J, Ross S, Knottnerus J (1998) Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol 51:367-375
32. Weill A, Vallier N, Salanave B, Bourrel R, Cayla M, Suarez C, Ricordeau P, Allemand H (2006) Frequency of thirty long-term illness for beneficiaries of the French general health insurance scheme in 2004. Pratiques et Organisation des soins 37:173-188
33. Zarei M, Chandran S, Compston A, Hodges J (2003) Cognitive presentation of multiple sclerosis: evidence for a cortical variant. J Neurol Neurosurg Psychiatry 74:872-877